Viola Heinzelmann‐Schwarz

ORCID: 0000-0002-4056-3225
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian cancer diagnosis and treatment
  • Glycosylation and Glycoproteins Research
  • Endometrial and Cervical Cancer Treatments
  • Cancer Cells and Metastasis
  • PARP inhibition in cancer therapy
  • Monoclonal and Polyclonal Antibodies Research
  • BRCA gene mutations in cancer
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Intraperitoneal and Appendiceal Malignancies
  • Uterine Myomas and Treatments
  • Immunotherapy and Immune Responses
  • RNA modifications and cancer
  • Galectins and Cancer Biology
  • CAR-T cell therapy research
  • Single-cell and spatial transcriptomics
  • Bone health and treatments
  • Wnt/β-catenin signaling in development and cancer
  • Oral and Maxillofacial Pathology
  • Genetic factors in colorectal cancer
  • Breast Cancer Treatment Studies
  • DNA Repair Mechanisms
  • Epigenetics and DNA Methylation
  • Pelvic floor disorders treatments
  • Cancer-related gene regulation

University Hospital of Basel
2016-2025

University of Basel
2016-2025

Olgahospital
2014-2024

Swiss Group For Clinical Cancer Research
2022-2023

Universitäts Frauenklinik
2016-2023

Peter MacCallum Cancer Centre
2012-2022

Hospital Base
2015-2022

National Cancer Centre Japan
2019-2022

UNSW Sydney
2011-2020

Royal Hospital for Women
2004-2020

The ability of circulating tumor cells (CTCs) to form clusters has been linked increased metastatic potential. Yet biological features and vulnerabilities CTC remain largely unknown. Here, we profile the DNA methylation landscape single CTCs from breast cancer patients mouse models on a genome-wide scale. We find that binding sites for stemness- proliferation-associated transcription factors are specifically hypomethylated in clusters, including OCT4, NANOG, SOX2, SIN3A, paralleling...

10.1016/j.cell.2018.11.046 article EN cc-by-nc-nd Cell 2019-01-01

First-generation immune checkpoint inhibitors, including anti-CTLA-4 and anti-programmed death 1 (anti-PD-1) antibodies, have led to major clinical progress, yet resistance frequently leads treatment failure. Thus, new targets acting on T cells are needed. CD33-related sialic acid-binding immunoglobulin-like lectins (Siglecs) pattern-recognition receptors binding a range of sialoglycan ligands, which appear function as self-associated molecular patterns (SAMPs) that suppress autoimmune...

10.1172/jci120612 article EN Journal of Clinical Investigation 2018-08-21

Endogenous costimulatory molecules on T cells such as 4-1BB (CD137) can be leveraged for cancer immunotherapy. Systemic administration of agonistic anti-4-1BB antibodies, although effective preclinically, has not advanced to phase 3 trials because they have been hampered by both dependency Fcγ receptor-mediated hyperclustering and hepatotoxicity. To overcome these issues, we engineered proteins simultaneously targeting a tumor stroma or antigen: FAP-4-1BBL (RG7826) CD19-4-1BBL. In the...

10.1126/scitranslmed.aav5989 article EN Science Translational Medicine 2019-06-12
Anja Irmisch Ximena Bonilla Stéphane Chevrier Kjong-Van Lehmann Franziska Singer and 95 more Nora C. Toussaint Cinzia Esposito Julien Mena Emanuela S. Milani Ruben Casanova Daniel J. Stekhoven Rebekka Wegmann Francis Jacob Bettina Sobottka Sandra Goetze Jack Kuipers Jacobo Sarabia del Castillo Michael Prummer Mustafa A. Tuncel Ulrike Menzel Alice K. Jacobs Stefanie Engler Sujana Sivapatham Anja Frei Gabriele Gut Joanna Ficek Nicola Miglino Rudolf Aebersold Marina Bacac Niko Beerenwinkel Christian Beisel Bernd Bodenmiller Reinhard Dummer Viola Heinzelmann‐Schwarz Viktor H. Koelzer Markus G. Manz Holger Moch Lucas Pelkmans Berend Snijder Alexandre Theocharides Markus Tolnay Andreas Wicki Bernd Wollscheid Gunnar Rätsch Mitchell P. Levesque Melike Ak Faisal Alquaddoomi Jonas Albinus Ilaria Alborelli Sonali Andani Per-Olof Attinger Daniel Baumhoer Beatrice Beck‐Schimmer Lara Bernasconi Anne Bertolini Natalia Chicherova Maya D’Costa Esther Danenberg Natalie R. Davidson Monica-Andreea Drăgan Martin Erkens Katja Eschbach André Fedier Pedro Ferreira Bruno S. Frey Linda Grob Detlef Günther Martina Haberecker Pirmin Haeuptle Sylvia Herter René Holtackers Tamara Huesser Tim M. Jaeger Katharina Jahn Alva Rani James Philip Jermann André Kahles Abdullah Kahraman Werner Kuebler Christian P. Kunze Christian Kurzeder Sebastian Lugert Gerd Maass Philipp Markolin Julian M. Metzler Simone Muenst Riccardo Murri Charlotte K.Y. Ng Stefan Nicolet Marta Nowak Patrick G. A. Pedrioli Salvatore Piscuoglio Mathilde Ritter Christian Rommel María L. Rosano-González Natascha Santacroce Ramona Schlenker Petra Schwalie Severin Schwan Tobias Schär

10.1016/j.ccell.2021.01.004 article EN publisher-specific-oa Cancer Cell 2021-01-21

Abstract Intratumoral tertiary lymphoid structures (TLSs) have been associated with improved outcome in various cohorts of patients cancer, reflecting their contribution to the development tumor-targeting immunity. Here, we demonstrate that high-grade serous ovarian carcinoma (HGSOC) contains distinct immune aggregates varying degrees organization and maturation. Specifically, mature TLSs (mTLS) as forming only 16% HGSOCs relatively elevated tumor mutational burden (TMB) are an increased...

10.1038/s41467-024-46873-w article EN cc-by Nature Communications 2024-03-21
Nicoletta Colombo Elena Biagioli Kenichi Harano Francesca Galli Emma Hudson and 95 more Yoland Antill Chel Hun Choi Manuela Rabaglio Frederic Marmé Christian Marth Gabriella Parma Lorena Fariñas-Madrid Shin Nishio Karen Allan Yeh Chen Lee Elisa Piovano Beatriz Pardo Satoshi Nakagawa John McQueen Claudio Zamagni Luís Manso Kazuhiro Takehara Giulia Tasca Annamaria Ferrero Germana Tognon Andrea Alberto Lissoni Mariacristina Petrella Maria Elena Laudani Eliana Rulli Sara Uggeri M.P. Barretina Ginesta Paolo Zola Cláudia Casanova Valentina Arcangeli Lorenzo Antonuzzo Angiolo Gadducci Stefania Cosio Andrew R. Clamp Mojca Persic Iain A. McNeish Laura A. Tookman Andrés Redondo Chel Hun Choi Editta Baldini Innocenza Palaia Pierluigi Benedetti Panici Nobutaka Takahashi Janine Lombard Antonio Ardizzoia Alessandra Bologna Ana Maria Herrero Ibáñez Antonino Musolino Raúl Márquez Vázquez Klaus Pietzner Elena Ioana Braicu Viola Heinzelmann‐Schwarz Melanie Powell Yoshihito Yokoyama Sally Baron‐Hay Chiara Abeni Cristina Martín Lorente Juan Cueva Fabian Trillsch Florian Heitz Beyhan Ataseven Edgar Petru MartinLeonhard Heubner Azmat Sadozye Sidharth Dubey Andrea Tazbirkova Susan Tiley K. Chrystal Sang Wun Kim Mathias Fehr Kate Scatchard Anjana Anand Alexandra A. Taylor Hidemichi Watary Takayuki Enomoto Kosuke Yoshihara Sudarsha Selva‐Nayagam Bhaskar Karki Michelle Harrison Kate Wilkinson Jeffrey C. Goh Amanda Glasgow Lorraine A. Chantrill Chulmin Lee A. Bertolini Filomena Narducci Giovanna Bellotti Vittorio Fusco Stefan Aebi Maria Del Grande Ilaria Colombo Hideki Tokunaga Shogo Shigeta Geraldine Goss Zhen R. Siow Christopher Steer

10.1016/s1470-2045(24)00334-6 article EN The Lancet Oncology 2024-08-02

Abstract The presence of circulating tumor cell (CTC) clusters is associated with disease progression and reduced survival in a variety cancer types. In breast cancer, preclinical studies showed that inhibitors the Na + /K ATPase suppress CTC block metastasis. Here we conducted prospective, open-label, proof-of-concept study women metastatic where primary objective was to determine whether treatment inhibitor digoxin could reduce mean cluster size. An analysis nine patients treated daily...

10.1038/s41591-024-03486-6 article EN cc-by Nature Medicine 2025-01-24

Abstract Purpose: A better understanding of the molecular pathways underlying development epithelial ovarian cancer (EOC) is critical to identify tumor markers for use in diagnostic or therapeutic applications. The aims this study were integrate results from 14 transcript profiling studies EOC novel biomarkers and examine their expression early late stages disease. Experimental Design: database incorporating genes identified as being highly up-regulated each was constructed. Candidate...

10.1158/1078-0432.ccr-04-0073 article EN Clinical Cancer Research 2004-07-01

Antibody-drug conjugates (ADC) are emerging as powerful treatment strategies with outstanding target-specificity and high therapeutic activity in patients cancer. Brentuximab vedotin represents a first-in-class ADC directed against CD30(+) malignancies. We hypothesized that its sustained clinical responses could be related to the stimulation of an anticancer immune response. In this study, we demonstrate dolastatin family microtubule inhibitors, from which cytotoxic component brentuximab is...

10.1158/2326-6066.cir-13-0198 article EN Cancer Immunology Research 2014-04-22

Selected reaction monitoring (SRM) is a targeted mass spectrometry technique that provides sensitive and accurate protein detection quantification in complex biological mixtures. Statistical computational tools are essential for the design analysis of SRM experiments, particularly studies with large sample throughput. Currently, most such focus on selection optimized transitions processing signals from assays. Little attention devoted to significance analysis, which combines quantitative...

10.1074/mcp.m111.014662 article EN cc-by Molecular & Cellular Proteomics 2011-12-22

Epithelial ovarian cancer is the fifth most common cause of in women worldwide bearing highest mortality rate among all gynecological cancers. Cell membrane glycans mediate various cellular processes such as cell signaling and become altered during carcinogenesis. The extent to which glycosylation changes are influenced by aberrant regulation gene expression nearly unknown for remains crucial understanding development progression this disease. To address effect, we analyzed non-cancerous...

10.1074/mcp.m113.037085 article EN cc-by Molecular & Cellular Proteomics 2014-05-23

The molecular repertoire promoting cancer cell plasticity is not fully elucidated. Here, we propose that glycosphingolipids (GSLs), specifically the globo and ganglio series, correlate promote transition between epithelial mesenchymal cells. character of ovarian remains stable throughout disease progression, spatial glycosphingolipidomics reveals elevated globosides in tumor compartment compared with ganglioside-rich stroma. CRISPR-Cas9 knockin mediated truncation endogenous E-cadherin...

10.1016/j.celrep.2022.111181 article EN cc-by Cell Reports 2022-08-01

Mucinous epithelial ovarian cancers (MOC) are clinically and morphologically distinct from the other histological subtypes of cancer. To determine genetic basis MOC to identify potential tumour markers, gene expression profiling 49 primary different was performed using a customised oligonucleotide microarray containing >59 000 probesets. The results show that express profile both differs overlaps with Concordant its phenotype, genes characteristic mucinous carcinomas varying origin,...

10.1038/sj.bjc.6603003 article EN cc-by-nc-sa British Journal of Cancer 2006-02-28

Abstract High-grade serous cancer (HGSC), the most common subtype of ovarian cancer, often becomes resistant to chemotherapy, leading poor patient outcomes. Intratumoral heterogeneity occurs in nearly all solid cancers, including contributing development resistance mechanisms. In this study, we examined spatial and temporal genomic variation HGSC using high-resolution single-nucleotide polymorphism arrays. Multiple metastatic lesions from individual patients were analyzed along with 22...

10.1158/0008-5472.can-12-0203 article EN Cancer Research 2012-08-14

Aberrant Wnt signalling is implicated in numerous human cancers, and understanding the effects of modulation pathway members may lead to development novel therapeutics. Expression secreted frizzled related protein 4 (SFRP4), an extracellular modulator pathway, progressively lost more aggressive ovarian cancer phenotypes. Here we show that recombinant SFRP4 (rSFRP4) treatment a serous cell line results inhibition β-catenin dependent as measured by TOP/FOP reporter assay decreased...

10.1371/journal.pone.0054362 article EN cc-by PLoS ONE 2013-01-11

In recent years, the Wnt signalling pathway has been implicated in epithelial ovarian cancer and its members have potential as diagnostic, prognostic therapeutic targets. Here we investigated role of two receptor tyrosine kinases (RTKs), ROR1 ROR2, their putative ligand, Wnt5a, cancer.Immunohistochemistry for ROR2 was performed a large patient cohort, including benign controls, borderline tumours cancer. addition, siRNA used to silence ROR1, Wnt5a individually, together, cell lines, effects...

10.18632/oncotarget.5643 article EN Oncotarget 2015-10-20
Stefan G. Stark Joanna Ficek Francesco Locatello Ximena Bonilla Stéphane Chevrier and 95 more Franziska Singer Rudolf Aebersold Faisal Alquaddoomi Jonas Albinus Ilaria Alborelli Sonali Andani Per-Olof Attinger Marina Bacac Daniel Baumhoer Beatrice Beck‐Schimmer Niko Beerenwinkel Christian Beisel Lara Bernasconi Anne Bertolini Bernd Bodenmiller Ximena Bonilla Ruben Casanova Stéphane Chevrier Natalia Chicherova Maya D’Costa Esther Danenberg Natalie R. Davidson Monica-Andreea Dră gan Reinhard Dummer Stefanie Engler Martin Erkens Katja Eschbach Cinzia Esposito André Fedier Pedro Ferreira Joanna Ficek Anja Frei Bruno S. Frey Sandra Goetze Linda Grob Gabriele Gut Detlef Günther Martina Haberecker Pirmin Haeuptle Viola Heinzelmann‐Schwarz Sylvia Herter René Holtackers Tamara Huesser Anja Irmisch Francis Jacob Alice K. Jacobs Tim M. Jaeger Katharina Jahn Alva Rani James Philip Jermann André Kahles Abdullah Kahraman Viktor H. Koelzer Werner Kuebler Jack Kuipers Christian P. Kunze Christian Kurzeder Kjong-Van Lehmann Mitchell Levesque Sebastian Lugert Gerd Maass Markus G. Manz Philipp Markolin Julien Mena Ulrike Menzel Julian M. Metzler Nicola Miglino Emanuela S. Milani Holger Moch Simone Muenst Riccardo Murri Charlotte K.Y. Ng Stefan Nicolet Marta Nowak Patrick G. A. Pedrioli Lucas Pelkmans Salvatore Piscuoglio Michael Prummer Mathilde Ritter Christian Rommel María L. Rosano-González Gunnar Rätsch Natascha Santacroce Jacobo Sarabia del Castillo Ramona Schlenker Petra Schwalie Severin Schwan Tobias Schär Gabriela Senti Franziska Singer Sujana Sivapatham Berend Snijder Bettina Sobottka Vipin T. Sreedharan Stefan G. Stark

Recent technological advances have led to an increase in the production and availability of single-cell data. The ability integrate a set multi-technology measurements would allow identification biologically or clinically meaningful observations through unification perspectives afforded by each technology. In most cases, however, profiling technologies consume used cells thus pairwise correspondences between datasets are lost. Due sheer size can acquire, scalable algorithms that able...

10.1093/bioinformatics/btaa843 article EN cc-by Bioinformatics 2020-09-14

The extracellular matrix (ECM) plays critical roles in tumor progression and metastasis. However, the contribution of ECM proteins to early metastatic onset peritoneal cavity remains unexplored. Here, we suggest a new route metastasis through interaction integrin alpha 2 (ITGA2) with collagens enriched coinciding poor outcome patients ovarian cancer. Using multiple gene-edited cell lines patient-derived samples, demonstrate that ITGA2 triggers cancer adhesion collagen, promotes migration,...

10.7554/elife.59442 article EN cc-by eLife 2020-10-07
Coming Soon ...